Quick Liquidity Indicator: Cryoport Corp (CYRX)

This chart of the quick ratio for Cryoport, Inc. (CYRX) on the GURU.Markets platform is fixed at 2.01. Cryoport, Inc. (CYRX) is expanding its cryogenic IT logistics through partnerships with cell therapy developers and mergers with manufacturing plants. The team relies on biomedical experts attracted by a unique technology stack. The business benefits from growing biopharmaceutical demand for ultra-low temperatures during transport.

CYRX: Cryoport Inc Intermediate Coverage Ratio 07/04/2022 - 10/30/2026

cryoport.com - analytical breakdowns and key metrics (CYRX)

- market value and analyst target forecast:

Price Chart Cryoport Systems|CYRX - Analyst Median Target

- company stock exchange capitalization indicators:

Market Valuation Cryoport Systems|CYRX - Aggregate Business Value

- book capitalization indicators:

Accounting Value per Share Cryoport|CYRX - Accounting Value of Company|Market Capitalization to Book Value Ratio cryoport.com|CYRX - Company Total Asset Base

- company total debt and liquidity indicators:

- earnings and valuation multiples information:

CYRX - Company Net Income

Basic company analysis:Cryoport, Inc.

As Cryoport, Inc. (CYRX) adapts to the normalization of demand within the cell therapy sector, working capital management becomes critically important. This ratio measures the company's ability to settle short-term debts using only cash and accounts receivable, completely ignoring low-liquidity inventories. This allows investors to assess real financial stability without accounting for warehouse risks. By analyzing the efficiency of covering current liabilities, one can judge whether the liquid reserve is sufficient for logistics automation.

Who Cryoport, Inc. competes with